Q2 2025 Earnings Estimate for Canopy Growth Co. (NASDAQ:CGC) Issued By Atb Cap Markets

Canopy Growth Co. (NASDAQ:CGC) – Investment analysts at Atb Cap Markets lowered their Q2 2025 earnings per share (EPS) estimates for Canopy Growth in a research report issued to clients and investors on Sunday, August 11th. Atb Cap Markets analyst F. Gomes now anticipates that the company will earn ($0.47) per share for the quarter, down from their prior estimate of ($0.37). Atb Cap Markets has a “Hold” rating on the stock. The consensus estimate for Canopy Growth’s current full-year earnings is ($1.07) per share. Atb Cap Markets also issued estimates for Canopy Growth’s Q3 2025 earnings at ($0.35) EPS, Q4 2025 earnings at ($0.29) EPS, FY2025 earnings at ($2.28) EPS, FY2026 earnings at ($0.50) EPS and FY2027 earnings at ($0.34) EPS.

Canopy Growth (NASDAQ:CGC) last announced its earnings results on Thursday, May 30th. The company reported ($0.28) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.05. Canopy Growth had a negative return on equity of 71.08% and a negative net margin of 240.19%. The business had revenue of $53.99 million during the quarter, compared to analysts’ expectations of $52.71 million.

Separately, Piper Sandler reduced their target price on Canopy Growth from $3.00 to $2.00 and set an “underweight” rating for the company in a report on Tuesday, July 9th.

Canopy Growth Price Performance

Shares of Canopy Growth stock opened at $6.98 on Wednesday. The business has a 50 day simple moving average of $6.92 and a two-hundred day simple moving average of $6.83. Canopy Growth has a 12 month low of $2.76 and a 12 month high of $19.20. The stock has a market capitalization of $592.32 million, a P/E ratio of -1.09 and a beta of 0.93. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.58 and a quick ratio of 1.25.

Insider Activity at Canopy Growth

In related news, Director Willy Kruh sold 3,738 shares of the stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $9.94, for a total value of $37,155.72. Following the completion of the sale, the director now owns 17,295 shares of the company’s stock, valued at $171,912.30. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Over the last 90 days, insiders sold 7,545 shares of company stock valued at $67,997. 0.35% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Canopy Growth

Hedge funds and other institutional investors have recently made changes to their positions in the stock. CIBC Asset Management Inc acquired a new stake in shares of Canopy Growth in the second quarter valued at approximately $91,000. Insigneo Advisory Services LLC purchased a new position in Canopy Growth in the second quarter worth approximately $96,000. Genesee Capital Advisors LLC grew its position in Canopy Growth by 15.3% in the second quarter. Genesee Capital Advisors LLC now owns 15,047 shares of the company’s stock worth $97,000 after acquiring an additional 2,000 shares during the period. Farallon Capital Management LLC purchased a new position in Canopy Growth in the second quarter worth approximately $194,000. Finally, Mackenzie Financial Corp grew its position in Canopy Growth by 13.2% in the second quarter. Mackenzie Financial Corp now owns 33,165 shares of the company’s stock worth $214,000 after acquiring an additional 3,864 shares during the period. Institutional investors and hedge funds own 3.33% of the company’s stock.

Canopy Growth Company Profile

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products.